Showing results (1441-1450 of 2,739) with videos related to

Sort By:
Pageof 274
Pharmacogenomics|October 5, 2017
The pharmacogenomics of severe traumatic brain injurySolomon M Adams, Yvette P Conley, Amy K Wagner, et al.
Pharmacogenomics|October 12, 2017
HLA-associated drug hypersensitivity and the prediction of adverse drug reactionsSimone Negrini, Laurent Becquemont
Pharmacogenomics|March 29, 2017
The influences of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of simvastatin, in relation to CYP3A4 inhibitionFen Jiang, Jong-Yeol Choi, Ju-Hyun Lee, et al.
Pharmacogenomics|March 29, 2017
Impact of CYP2D6 genotype on amitriptyline efficacy for the treatment of diabetic peripheral neuropathy: a pilot studyMamoonah Chaudhry, Marco Alessandrini, Jacobus Rademan, et al.
Pharmacogenomics|January 14, 2017
Donors FMO3 polymorphisms affect tacrolimus elimination in Chinese liver transplant patientsLei Ren, Mujian Teng, Tao Zhang, et al.
Pharmacogenomics|January 14, 2017
Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough: a genome-wide association study in a Swedish populationPär Hallberg, Matilda Persson, Tomas Axelsson, et al.
Pharmacogenomics|September 28, 2016
Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcomeAurea Lima, Miguel Bernardes, Rita Azevedo, et al.
Pharmacogenomics|August 2, 2019
Pharmacomicrobiomics informs clinical pharmacogenomicsTheodora Katsila, Angeliki Balasopoulou, Ioanna Tsagaraki, et al.
Pharmacogenomics|August 2, 2019
Colorectal cancer: pharmacogenetics support for the correct drug prescriptionGladys Olivera, Luis Sendra, María José Herrero, et al.
Pharmacogenomics|August 2, 2019
Resequencing CYP2D6 gene in Indian population: CYP2D6*41 identified as the major reduced function alleleAarthi Manoharan, Deepak Gopal Shewade, Pradeep Anand Ravindranath, et al.
Pageof 274